morpholine has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, JW; Han, SH; Heo, JY; Hwang, O; Kim, DJ; Kim, J; Kim, JH; Kim, SJ; Lee, JA; Park, KD; Shin, N; Son, HJ | 1 |
1 other study(ies) available for morpholine and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Activation of the Nrf2 signaling pathway and neuroprotection of nigral dopaminergic neurons by a novel synthetic compound KMS99220.
Topics: Animals; Dopaminergic Neurons; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred C57BL; Morpholines; MPTP Poisoning; Neuroprotection; Neuroprotective Agents; NF-E2-Related Factor 2; Rats, Sprague-Dawley; Signal Transduction; Substantia Nigra | 2018 |